Then, to explore the effect of metformin on OE‐Nap1l2 BMSCs, metformin‐treated OE‐Nap1l2 BMSCs were administered through tail vein injection in IBD and EAE mice. This evidence concerns the gene NAP1L2 and inflammatory bowel disease.